Physician profile
Michael Plishchuk
NPI 1760675789
$9,852.38
in general payments reported to CMS, 2019-2025
38 companies · $1,820 in 2025
The $1,820 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $766 · 2021: $755 · 2022: $2,251 · 2023: $1,258 · 2024: $2,104 · 2025: $1,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,166 · Travel and Lodging: $16.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,165.89 |
| Travel and Lodging | $16.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,049.51 | 2019-2025 | Puraforce, Puraply, Puraply Wound Matrix |
| Kerecis Limited | $1,512.17 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $787.22 | 2019-2025 | Grafix Pl, Oasis, Stravix Mesh |
| Abbvie INC. | $594.00 | 2021-2025 | |
| Musculoskeletal Transplant Foundation INC. | $590.20 | 2019-2024 | |
| Abbott Laboratories | $584.65 | 2021-2024 | Proclaim, Eterna |
| Integra Lifesciences Corporation | $551.95 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Amgen INC. | $495.45 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $293.36 | 2022-2025 | Closurefast, Intellis Adaptivestim |
| Paratek Pharmaceuticals, INC. | $231.01 | 2020-2023 | Nuzyra |
| Convatec INC. | $225.67 | 2024-2025 | |
| Urgo Medical North America, LLC | $157.02 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag, Urgok2 |
| Zimmer Biomet Holdings, INC. | $140.08 | 2021 | |
| Inari Medical, INC. | $139.58 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medline Industries LP | $137.87 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reapplix INC. | $122.88 | 2024-2025 | 3c Patch Kit - Box |
| Cardiovascular Systems INC. | $120.67 | 2020 | |
| Advanced Oxygen Therapy INC. | $118.04 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Stryker Corporation | $114.38 | 2022 | |
| Mimedx Group, INC. | $111.48 | 2025 | |
| Nevro Corp. | $109.49 | 2022 | |
| Boston Scientific Corporation | $98.98 | 2020 | |
| Melinta Therapeutics, LLC | $82.45 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $72.05 | 2019 | |
| Tactile Systems Technology INC | $59.51 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Medtronic Vascular, INC. | $48.17 | 2019 | |
| Hydrofera LLC | $42.14 | 2022-2023 | Hydrofera Blue |
| Heron Therapeutics, INC. | $40.06 | 2021 | |
| Allergan, INC. | $39.81 | 2019-2020 | |
| Sebela Pharmaceuticals INC. | $39.09 | 2019-2020 | |
| Bioventus LLC | $38.00 | 2022 | |
| Acera Surgical, INC. | $18.79 | 2022 | |
| Zimvie INC. | $18.34 | 2022 | |
| Wright Medical Technology, INC. | $17.87 | 2019 | |
| Merck Sharp & Dohme LLC | $14.18 | 2019 | |
| Tenex Health INC. | $14.01 | 2019 | |
| Nabriva Therapeutics, Plc | $11.65 | 2022 | |
| Cashflow Solutions, LLC | $10.60 | 2024 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Plishchuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.